glp 1 and cannabinoids in Metabolic Syndrome Cardiac Fibrosis | Current Hypertension Reports Putative mechanisms underlying CNS access

Purpose-built for physicians Preconception GLP-1 receptor agonist use may reduce pregnancy risks Key takeaways: GLP-1 receptor agonist use before pregnancy was tied to lower risks for hypertensive disorders of pregnancy and gestational diabetes

Hemolysis is the rupture of red blood cells, which can lead to anemia and other complications

Phys Chem Chem Phys

EPT3 was activated only by Mn 2+ among nine tested metal ions [12]

A low dose of pasireotide prevents hypoglycemia in Roux-en-Y gastric bypass-operated individuals

Nausea is the most common side-effect GLP-1 symptom, followed by vomiting, sour burps, heartburn and gastroparesis Side-Effect Profile of GLP-1s, from Worst to Best (% reflects estimated number of patients with GI side-effects) 50% Semaglutide (Ozempic, Rybelsus, Wegovy) 40% Tirzepatide (Saxenda, Mounjaro) 40% Liraglutide (Victoza, Saxenda) 30% Lixisenatide (Adlyxin USA, Lyxumia UK) 10% Dulaglutide (Trulicity) 10% Exenatide (Byetta, Bydureon) Wegovy, Mounjaro, and Saxenda FDA-approved for weight loss